Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 85 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Suhas K.

India

USD 85 /hr

Freelance Consultant Virologist| Expert in Vaccine research and development| medical writer, 10+ years of experience

Profile Summary

A conscientious and professional medical biotechnologist, virologist, vaccinologist, and a research veterinarian with extensive experience in viral vaccines, antivirals, monoclonal antibody, and animal models development. A highly organized and efficient individual, whose thorough and precise approach to projects has yielded excellent results.

Subject Matter Expertise

• ★ Virology
• ☆ Microbiology
• ☆ Enteroviruses
• ☆ Monoclonal Antibody Production
• ☆ Microscopy
• ☆ Antibody Engineering
• ☆ Veterinary Medicine
• ☆ Vaccine Development
• ☆ COVID-19

Services

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Clinical Trial Documentation, Technical Writing

Research Market Research, Feasibility Study, Fact Checking, Gray Literature Search, Systematic Literature Review, Secondary Data Collection

Consulting Scientific and Technical Consulting

Data & AI Statistical Analysis

Product Development Formulation

Work Experience

Associate Director and Head-R&D

Hester Biosciences Ltd

November 2020 - Present

Consultant Virologist

Freelance

February 2020 - Present

Research Scientist

Ghent University

July 2014 - December 2019

Research coordinator/Medical Scientist

Vaxine Pty Ltd

April 2013 - July 2014

Virologist/Officer/Visiting lecturer

Temasek life sciences laboratory limited, NUS, Singapore

November 2009 - February 2013

Education

PhD in Biochemistry and Biotechnology

VIB-Ghent University, Belgium

July 2014 - June 2018

Masters in Virology

ICMRs-National Institute of Virology, Pune, India

July 2006 - June 2008

BVSc & AH (Veterinary Medicine)

Bombay Veterinary College, MAFSU, Mumbai, India

July 2001 - June 2006

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Kolpe, A., Arista-Romero, M., Schepens, B., Pujals, S., Saelens, X., Albertazzi, L.(2019). Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface . Scientific Reports. 9. (1).

Kolpe, A., Schepens, B., Ye, L., Staeheli, P., Saelens, X.(2018). Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice . Antiviral Research. 158. p. 244-254.

Eliasson, D.G., Omokanye, A., Schön, K., Wenzel, U.A., Bernasconi, V., Bemark, M., Kolpe, A., El Bakkouri, K., Ysenbaert, T., Deng, L., et al.(2018). M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection . Mucosal Immunology. 11. (1). p. 273-289.

Van den Hoecke, S., Ehrhardt, K., Kolpe, A., El Bakkouri, K., Deng, L., Grootaert, H., Schoonooghe, S., Smet, A., Bentahir, M., Roose, K., et al.(2017). Hierarchical and redundant roles of activating FcγRs in protection against influenza disease by M2e-specific IgG1 and IgG2a antibodies . Journal of Virology. 91. (7).

Verhelst, J., Van Hoecke, L., Spitaels, J., De Vlieger, D., Kolpe, A., Saelens, X.(2017). Chemical-controlled activation of antiviral myxovirus resistance protein 1 . Journal of Biological Chemistry. 292. (6). p. 2226-2236.

Kolpe, A., Schepens, B., Fiers, W., Saelens, X.(2017). M2-based influenza vaccines: recent advances and clinical potential . Expert Review of Vaccines. 16. (2). p. 123-136.

Slowicka, K., Vereecke, L., Mc Guire, C., Sze, M., Maelfait, J., Kolpe, A., Saelens, X., Beyaert, R., van Loo, G.(2016). Optineurin deficiency in mice is associated with increased sensitivity to Salmonella but does not affect proinflammatory NF-κB signaling . European Journal of Immunology. 46. (4). p. 971-980.

Honda-Okubo, Y., Kolpe, A., Li, L., Petrovsky, N.(2014). A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection . Vaccine. 32. (36). p. 4651-4659.

Prabakaran, M., Kolpe, A.B., He, F., Kwang, J.(2013). Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge . Vaccine. 31. (10). p. 1385-1392.

Kolpe, A.B., Kiener, T.K., Grotenbreg, G.M., Kwang, J.(2012). Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice . Virus Research. 168. (1-2). p. 64-72.

Chitambar, S.D., Arora, R., Kolpe, A.B., Yadav, M.M., Raut, C.G.(2011). Molecular characterization of unusual bovine group A rotavirus G8P[14] strains identified in western India: Emergence of P[14] genotype . Veterinary Microbiology. 148. (2-4). p. 384-388.

Meng, T., Meng, T., Kolpe, A.B., Kiener, T.K., Chow, V.T.K., Kwang, J.(2011). Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous Human Enterovirus 71 strains in mice . PLoS ONE. 6. (7).